Insilico Medicine
0 followers
About Insilico Medicine
Insilico Medicine leverages generative artificial intelligence and automation to accelerate drug discovery and aging-related research from discovery through development. The company operates globally with facilities in Boston, Hong Kong, Abu Dhabi, and Shanghai, focusing on AI-driven biology, target identification, and therapeutic program development through its Pharma.ai suite and science platforms like PandaOmics, Chemistry42, Generative Biologics, and inClinico. Its mission is to extend healthy longevity and sustainability by reducing time and cost to bring life-saving medications to patients. The company emphasizes multidisciplinary collaboration across biotechnology, computational biology, and translational medicine to create novel therapeutics.